Mizuho Securities Reiterates Buy Rating on CVS Health (CVS) Following 3Q EPS Beat

CVS Health (CVS) PT Raised to $83 at Citi

November 7, 2019 5:28 AM EST

Citi analyst Ralph Giacobbe raised the price target on CVS Health (NYSE: CVS) to $83.00 (from $72.00) while maintaining a Buy rating.... More

CVS Health (CVS) PT Raised to $78 at UBS

November 7, 2019 5:15 AM EST

UBS raised its price target on CVS Health (NYSE: CVS) to $78.00 (from $71.00) while maintaining a Buy rating.... More

CVS Health (CVS) PT Raised to $79 at Barclays

November 7, 2019 4:43 AM EST

Barclays raised its price target on CVS Health (NYSE: CVS) to $79.00 (from $75.00) while maintaining a Overweight rating.... More

CVS Health (CVS) PT Raised to $85 at Cantor Fitzgerald

November 6, 2019 12:10 PM EST

Cantor Fitzgerald analyst Steven Halper raised the price target on CVS Health (NYSE: CVS) to $85.00 (from $80.00) while maintaining a Overweight rating.

The analyst commented, "We reiterate our Overweight rating on CVS shares and increase our price target to $85 from $80. On November 6,... More

CVS Health (CVS) Trades to High, Up 5% Following Results Earllier

November 6, 2019 10:01 AM EST

CVS Health (NYSE: CVS) Trades to High, Up 5% Following Results Earllier

... More

Wall St. ends near flat; healthcare shares gain but trade deal delay weighs

November 6, 2019 8:00 AM EST

By Caroline Valetkevitch

NEW YORK (Reuters) - U.S. stocks ended little changed on Wednesday as a report the U.S.-China trade deal could be delayed until December was offset by gains in healthcare shares.

The Nasdaq broke a three-day string of record closing highs, and the Dow barely snapped its two-day run of record highs.

A senior official of the Trump administration told Reuters a meeting between U.S. President Donald Trump and Chinese President Xi Jinping to sign a long-awaited interim trade deal could be delayed until December, as discussions continue over terms and a... More

CVS quarterly profit beats expectations; shares rise as it eyes growth

November 6, 2019 7:01 AM EST

By Caroline Humer and Manas Mishra

(Reuters) - CVS Health Corp (NYSE: CVS) reported higher-than-expected third-quarter profit on Wednesday as medical costs in its Aetna health insurance business came in below forecasts, and the company said its new strategy of using in-pharmacy clinics would contain healthcare spending going forward.

Shares of CVS, which runs a national drugstore chain, rose more than 5%, as its pharmacy benefits business also posted better-than-expected operating profit.

CVS completed its purchase of Aetna last year, combining one of the largest U.S. pharmacy benefit managers... More

CVS Health (CVS) Tops Q3 EPS by 7c, Raises FY EPS Guidance

November 6, 2019 6:32 AM EST

CVS Health (NYSE: CVS) reported Q3 EPS of $1.84, $0.07 better than the analyst estimate of $1.77. Revenue for the quarter came in at $64.8 billion versus the consensus estimate of $63.01 billion.

GUIDANCE:

CVS Health sees FY2019 EPS of $6.97-$7.05, versus the consensus of... More

CVS Health (CVS) November weekly option implied volatility elevated into EPS and outlook

November 6, 2019 4:52 AM EST

CVS Health (NYSE: CVS) November weekly call option implied volatility is at 67, November is at 42; compared to its 52-week range of 22 to 40 into the expected release of quarter results today before the bell.

... More

Options expected to have increasing volume: WBA CVS HUM LL WEN WYNN

November 6, 2019 4:24 AM EST

Options expected to have increasing volume: WBA CVS HUM LL WEN WYNN

... More

UPS drone makes first home prescription deliveries for CVS

November 5, 2019 3:55 PM EST

By Lisa Baertlein

LOS ANGELES (Reuters) - United Parcel Service Inc (NYSE: UPS) Flight Forward drones have flown prescription medications to the front lawn of a private home and to a retirement center, the UPS unit's first revenue-generating deliveries for drugstore chain CVS Health Corp (NYSE: CVS).

Flight Forward's maiden delivery flight on Friday in Cary, North Carolina, beat rivals in one... More

Exclusive: Walgreens has explored taking drug store chain private - sources

November 5, 2019 1:42 PM EST

By Greg Roumeliotis and Mike Spector

(Reuters) - Walgreens Boots Alliance Inc (NASDAQ: WBA) has been exploring whether to go private following private equity interest in the U.S drug store chain, which has a market value of more than $55 billion, according to people familiar with the matter.

In recent months, Walgreens has held preliminary discussions with some of the world's largest private equity firms about putting together what would be the biggest ever leveraged buyout, the sources said.

Walgreens has tasked investment bank Evercore Partners Inc (NYSE:... More

CVS Health (CVS) option implied volatility elevated into EPS and outlook

November 5, 2019 1:16 PM EST

CVS Health (NYSE: CVS) November weekly call option implied volatility is at 65, November is at 40; compared to its 52-week range of 22 to 40 into the expected release of quarter results after the bell on November 7.

... More

UPS (UPS) and CVS (CVS) Make First Residential Drone Deliveries Of Prescription Medicines

November 5, 2019 7:48 AM EST

Flights were the first commercial drone deliveries of a medical prescription in the United States under an FAA-approved programUPS and CVS exploring a variety of drone delivery use casesUPS Flight Forward expanding drone delivery beyond hospital campuses

UPS (NYSE: UPS) subsidiary... More